APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
2,913,378
Share change
+2,254,273
Total reported value
$106,761,000
Price per share
$36.65
Number of holders
34
Value change
+$86,547,216
Number of buys
27
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q4 2020

As of 31 Dec 2020, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,913,378 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP, BlackRock Inc., Ghost Tree Capital, LLC, Alyeska Investment Group, L.P., Anson Funds Management LP, and BANK OF MONTREAL /CAN/. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.